bio in Biological Technology
Navigation Links
bio in Biological Technology
SynCo Bio Partners Increases its Capacities by Expanding its Quality Team
AMSTERDAM, July 20 /PRNewswire/ -- SynCo Bio Partners B.V., the GMP contract manufacturer of biological-based vaccines and therapeutics, today announced that it had significantly expanded the number of clinical and commercial biopharmaceutical batches it is capable of releasing annually, whils...GPhA Says BIO Cries Wolf on Senate Biogenerics Proposal
ARLINGTON, Va., July 9 /PRNewswire/ -- The Generic Pharmaceutical Association (GPhA) released the following statement today from GPhA President and CEO Kathleen Jaeger on The Biotechnology Industry Organization's (BIO's) erroneous claims regarding the Senate HELP Biogenerics amendments. "BIO'...iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
SOUTH SAN FRANCISCO, Calif. and BOSTON, July 8 /PRNewswire/ -- iZumi Bio, Inc. and Pierian, Inc. today announced they have merged to form a new company, iPierian, Inc. Building on the iZumi infrastructure and vision, the company is focused on the application of cellular reprogramming to change the...National Institutes of Health Join Nation's Leading Postgrad Bio Jobs Board
SANTA CRUZ, Calif., June 16 /PRNewswire/ -- Six prestigious members of the National Institutes of Health have joined Bio Career Center ( www.BioCareerCenter.com ), the nation's leading online jobs board and careers site for life science professionals. The NIH has the highest number of post-...iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
SOUTH SAN FRANCISCO, Calif., June 11 /PRNewswire/ -- iZumi Bio, Inc., a biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient ...As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention
$11 Million in New Projects Approved in Atlanta ATLANTA, May 19 /PRNewswire-USNewswire/ -- Meeting at the world's largest bioscience and biotechnology convention, the Kansas Bioscience Authority has approved more than $11 million in new investments as part of a $581 million initiative to hel...Interleukin Genetics to Present at the 2009 BIO Business Forum
WALTHAM, Mass. , May 15 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (NYSE Amex: ILI ) announced today that it will be presenting at the BIO 2009 Business Forum on Wednesday, May 20, 2009, at 2:40 p.m. EDT in Room 313 at the Sheraton Atlanta Hotel in Atlanta, GA. Lewis H. Bender, Chief ...Spherix to Exhibit at the BIO 2009 International Convention
BETHESDA, Md., May 14 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will e...BioMS Medical to participate in panel session at Bio International Convention 2009
- "BioMS/Eli Lilly - Dissecting a Billion Dollar Collaboration" - Toronto Stock Exchange Symbol: MS EDMONTON, May 14 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Richard Brown, Vice Presid...NEWTOWN SQUARE, Pa., May 14 /PRNewswire/ -- The Philadelphia area-based probiotics firm Kibow Biotech will be one of only three (3) Pennsylvania companies invited to present at the BIO 2009 Company Forum, http://www.convention.bio.org , in Atlanta, GA on Tuesday, May 19. BIO is the world's la...
BOSTON, May 14 /PRNewswire-FirstCall/ -- Experts from PAREXEL Consulting will present insights into achieving regulatory approval at the BIO International Convention, to be held May 18-21, 2009 at the Georgia World Congress Center in Atlanta, Georgia. PAREXEL Consulting is a business unit of PAREX...
Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
SEATTLE, May 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 2009 BIO International Convention at the Georgia International Convention Center in Atlanta, Georgia, on Tuesday, May 19th at 10:40 AM in Room 311 of Building A, Level 3. ...Poniard Pharmaceuticals to Present at the 2009 BIO International Convention
- Presentation to Include Partnering Strategy and Process for Picoplatin - SOUTH SAN FRANCISCO, Calif., May 12 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Ronald Martell, ...Four Major Universities Join Nation's Leading Postgrad Bio Jobs Board
SANTA CRUZ, Calif., May 12 /PRNewswire/ -- Four prestigious universities have joined Bio Career Center, the nation's leading online jobs board and careers site for life science professionals. UCLA , Brown , NYU and Georgetown are now members of the jobs board, joining 15 other majo...BlueFire Ethanol To Present at BIO 2009 International Convention
IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company changing the world's transportation fuel paradigm through the production of ethanol from non-food cellulosic wastes, has announced that the company's President and CEO, Arnold Klann,...GeoVax to Exhibit at the 2009 BIO International Convention
Dr. Harriet Robinson to Host HIV Vaccine Panel Discussion ATLANTA, May 11 /PRNewswire-FirstCall/ -- WHAT: GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases ca...SOUTH SAN FRANCISCO, Calif., May 6 /PRNewswire/ -- iZumi Bio, Inc., a biotechnology company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient cells,...
SynCo Bio Partners Wins Best Contract Manufacturing Organization 2009 ViE Award
AMSTERDAM, April 30 /PRNewswire/ -- SynCo Bio Partners B.V. (Amsterdam, The Netherlands), the cGMP manufacturer of clinical and commercial biopharmaceuticals, has won the Vaccine Industry Excellence (ViE) award for Best Contract Manufacturing Organization (CMO) 2009. This award was presented t...Genopole(R) to Accompany 7 Companies and a Research lab to BIO Atlanta
EVRY, France, April 23 /PRNewswire/ -- The 2009 edition of the Biotechnology Industry Organization (BIO) Conference and Exhibition will take place in Atlanta from May 18th-20th. Genopole(R) will participate in this major event as part of a delegation from the Paris Ile-de-France Region. Seven ...CALGARY, April 6 /PRNewswire/ - Orcrist Bio Inc. (ORC) a biotechnology company developing stem cell-mobilizing pharmaceuticals, announced today the approval of its Phase I, open-label, single-ascending-dose, safety study of HYC750 in healthy male volunteers, by the European Competent Authority in ...
Cynvec to Present at the BIO National Venture Conference
NEW YORK, March 25 /PRNewswire/ -- Cynvec LLC, a privately held biotechnology company focused on developing novel cancer therapies that harness the apoptotic ability of the sindbis viral vector, today announced that Frank Stonebanks, President and Chief Executive Officer, will present at the BIO N...China Bio Energy Reports Fourth Quarter and Record 2008 Financial Results
XI'AN, China, March 23 /PRNewswire-Asia-FirstCall/ -- China Bio Energy Holdings Group (OTC Bulletin Board: CBEH), a leading manufacturer and distributor of bio-diesel and distributor of petroleum-related products including gasoline, diesel, and heavy oil in China, today announced its financial...Clean Technology '09, Nanotech '09 and the TechConnect Summit are the Largest Events in the World Dedicated to Bringing Nano, Bio and Clean Tech Solutions From Development to Commercialization CAMBRIDGE, Mass., Feb. 26 /PRNewswire/ -- TechConnect World, in association with the Nano Science a...
GeoVax Update Provided at the BIO CEO & Investor Conference 2009
ATLANTA, Feb. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that Robert McNall...CALGARY, Feb. 9 /PRNewswire/ - Orcrist Bio Inc. (ORC) a biotech company developing stem cell-mobilizing pharmaceuticals, announced today that it has filed with the European Competent Authority in Seville, Spain, a Phase I, open-label, single-ascending-dose, safety study of HYC750 in healthy male v...
Cell Therapeutics, Inc. (CTI) BIO CEO Presentation to be Webcast
SEATTLE, Feb. 9 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management's presentation at the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10th at 9:30 AM Eastern will be webcast live with slides at http://www.celltherapeutics.com . ...Transcept Pharmaceuticals to Present at 11th Annual BIO CEO & Investor Conference
PT. RICHMOND, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. announced today that Glenn A. Oclassen, President & Chief Executive Officer, is scheduled to present at the 11th Annual BIO CEO & Investor Conference in New York City on Monday, February 9, 2009 at 9...BioMS Medical to present at BIO CEO and Investor Conference
Toronto Stock Exchange Symbol: MS EDMONTON, Feb. 5 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at The 11th Annual BIO CEO & Investor Conference...Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009
BETHESDA, Md., Feb. 5 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), today announced that its President and CEO, Dr. Christian Itin, will present at the BIO CEO and Investor Conference at the Waldorf-Astoria in New York City on Tuesday, February 10, 2009. A simultaneous webcast of the...Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the 11th Annual BIO CEO & Investor Conference. The details are as follows: ...NeurogesX to Present at 11th Annual BIO CEO & Investor Conference
SAN MATEO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that Anthony DiTonno, President and Chief Executive Officer, is scheduled to present at the ...Sunesis to Present at the 11th Annual BIO CEO & Investor Conference
SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that the ...GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference
ATLANTA, Feb. 4 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based, publicly traded biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced that its Corpor...Alexza's Corporate Presentation to be Webcast at the 11th Annual BIO CEO & Investor Conference
MOUNTAIN VIEW, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today that company President and CEO Thomas B. King will present during the 11th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2009 at 2:45 p.m. ET. The present...Advanced Life Sciences to Present at the 11th Annual BIO CEO & Investor Conference
CHICAGO, Feb. 3 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS ), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases today announced that ...Poniard Pharmaceuticals to Present at the BIO CEO & Investor Conference
SOUTH SAN FRANCISCO, Calif., Feb. 3 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the 11th Annual BIO CEO & Invest...Oncothyreon to present at BIO CEO & Investor Conference 2009
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that Robert Kirkman, M.D., President and Chief Executive Officer, will pres...Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
SEATTLE, Feb. 3 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN ) today announced that management will present a company update at the Eleventh Annual BIO CEO & Investor Conference in New York City, on Tuesday, February 10, 2009 at 1:45 p.m. ET. A live audio webcast o...VALENCIA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD ), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the 11th Annual Biotechnology Industry Organization BIO CEO & Investor C...
Repligen to Present at the BIO CEO & Investor Conference Monday, February 9th, 11:30 a.m. EST
WALTHAM, Mass., Feb. 2 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN ) announced today that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will present at the BIO CEO and Investor Conference on Monday, February 9th, 2009 at 11:30 a.m. EST at the Waldo...Other TagscannotCATICATICATICATICATICATICATICATIcollegesAMAAMAAMAAMAAMAAMASBIROther Contentssprainssprainssprainssquamoussquamoussquamoussquamoussquamoussputumsputumspurspurspurspursquintsteinaureusaureusaureusaureusaureusaureusstaphylococcusstaphylococcus
(Date:12/1/2009)... United States, the other from Canada, put the sat...ck, on remote Ellesmere Island, only 600 miles fro...what these "North Pole wolves" do in the long, dar...he world., "We first encountered 9-year-old Brut... Geological Survey (USGS) wolf researcher who has ...
(Date:12/1/2009)...wire/ -- iQor, a global provider of business proce... 2009 InfoWorld 100 Awards Top 100 IT project of... This was the first submission for iQor. ,, "We...us list of companies," said Vikas Kapoor, presiden...ng the way we do business, allowing us to work fas...
(Date:12/1/2009)...ideo of individual breast tissue cells reveals a n...otein that cycles between two major compartments i...mplete view of the internal signals that cause bre...ancer and are targets of drug development. , Th... factors, travels back and forth between the nucle...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 2ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 3ERK's got rhythm: Protein that controls cell growth found to cycle in and out of cell nucleus 4The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 1The Jones Center for Diabetes 26amp 3B Endocrine Wellness Selects Retasure to Enhance Diabetes Care 54138 2UT Southwestern physicians bust myths about insulin 54134 1UT Southwestern physicians bust myths about insulin 54134 2Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 1Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock 13480 2(Date:12/1/2009)...easingly common but more easily identified, study ...s) -- A magnetic resonance imaging test is highly...cy complication called placenta accreta, researche...enta surrounding a fetus attaches too deeply to a ...pull out parts of the uterine wall, rupturing bloo...
(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...
(Date:12/1/2009)...NS, Dec. 1 The American...professional association of blood specialists, exp...nual Meeting from December 5-8, 2009, at the Ernes...The meeting will showcase the latest research and ...leasure to host ASH,s 51st annual meeting, where w...
(Date:12/1/2009)...TON, Dec. 1 On December...,538 federal prisoners were HIV positive or had co...S) in the Office of Justice Programs, U.S. Departm...an estimated 5,672 inmates in state and federal pr... In 2007, about 43 per 10,000 prison inmates were ...
(Date:12/1/2009)...evelopment of simple screening test, expert says ,...n a finding that could lead to a simple blood test...identified immune system markers that indicate ear...ng cancer. , The researchers examined gene expr...with non-small cell lung cancer and a control grou...
Breaking Medicine News(10 mins):Health News:Serious Pregnancy Complication Detected With MRI 2Health News:National HIV Non-Profit Announces New Name 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:Gene 'Signature' May Point to Lung Cancer 2[0] Serious Pregnancy Complication Detected With MRI[3] National HIV Non-Profit Announces New Name[1] 51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care[0] Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population[0] Gene 'Signature' May Point to Lung Cancer
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |